For example, a low-molecular-weight inhibitor of DPP4 activity was found in sera from patients with metastatic prostate cancer [13], perhaps related to glypican-3, recently reported as a natural inhibitor of CD26/DPP4 enzymatic activity [14], usually absent in adult tissues though expressed in many tumours. Here, DPP4 is linked to neoplasm.